Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

byBenzinga Newsdesk

August 29, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

Lululemon Stock Stretches Higher: What’s Going On?

By Adam Eckert

March 29, 8:51 AM

Lululemon Athletica Inc (NASDAQ: LULU) shares are trading higher Wednesday after the athleisure company reported better-than-expected financial results and iss

LULU

What’s Going On With Blink Charging Shares Wednesday?

By Nabaparna Bhattacharya

April 24, 12:37 PM

Blink Charging collaborates with Evri to install EV charging hub at UK sorting center, part of larger net-zero emissions program, prompting slight decline in BLNK shares.

BLNK

Analyst Ratings

Where BioXcel Therapeutics Stands With Analysts

By Benzinga Insights

May 26, 10:00 AM

Over the past 3 months, 8 analysts have published their opinion on BioXcel Therapeutics (NASDAQ:BTAI) stock. These analysts…

BTAI

Air France-KLM In Discussions With Apollo Global Management For €500M Financing

By Akanksha Bakshi

May 5, 8:18 AM

Air France-KLM (OTC:AFLYY) and Apollo Global Management Inc (NYSE:APO) are in talks about a €500 million financing of a dedicated operating affiliate owning…

AFLYY

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Related Posts

Lululemon Stock Stretches Higher: What’s Going On?

What’s Going On With Blink Charging Shares Wednesday?

Where BioXcel Therapeutics Stands With Analysts

Air France-KLM In Discussions With Apollo Global Management For €500M Financing